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The objective of this research is to identify stakeholder views with regard to the development of 
effective powered wheelchair assistive technologies more suited to the user and carer needs, whilst 
also meeting the requirements for other stakeholders, such that developers can be better guided 
towards producing solutions which have a better chance of getting to the market place and hence to 
the end user. 
Method  
A questionnaire was designed to collect the views of all stakeholders and circulated to a statistically 
representative number of them. The question rating data was then checked for correlation between 
groups, and within groups, to establish validity. 
Results  
The 74 stakeholders across the eight classes who responded had a good correlation between each 
other, with a ĐƌŽƐƐĐůĂƐƐ ‘WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶ ?ƌĂŶŐŝŶŐďĞƚǁĞĞŶ ? ? ?ĂŶĚ ? ? ? ? ?ĂŶĚƚŚĞ ‘&ůĞŝƐƐ ?Ɛ<ĂƉƉĂ
ƌĞůŝĂďŝůŝƚǇŽĨĂŐƌĞĞŵĞŶƚ ?ǁŝƚŚŝŶĞĂĐŚĐůĂƐƐƌĂŶŐŝŶŐďĞƚǁĞĞŶ ? ? ? ?ĂŶĚ0.36.  
Conclusions  
This research has identified that all stakeholders should be involved in the development of the 
technology and that some may benefit in  ‘ƌŽůĞ-reversal ? to help understand user problems and 
stakeholder concerns more clearly. Cost was a significant barrier to the uptake of appropriate 
technology, and training of users and carers was a major issue. Furthermore development should 
not increase user isolation and the impact on the user must be monitored for  ‘quality of life ? ?
Technical support and training should be given to the user and their carers and equipment must be 
adaptive to meet the changing needs of the user. 
Introduction 
This research has sought to determine the problems with regard to the development of smart 
assistive powered wheelchairs such that one mass produced device can be used by a wide range of 
users, each with individual needs which may change over time. Whilst the principal of involving a 
wide range of stakeholder in order to identify problems and issues could be applied to the 
development of other assistive technology we have taken development of a smart assistive powered 
wheelchair as the core technology with the users and other stakeholders targeted towards this.  
According to the UK Government, the term assistive technology is best described as a device which 
mitigates the effect of ĂŶ ŝŶĚŝǀŝĚƵĂů ?Ɛ ĚŝƐĂďŝůŝƚǇ, such that the technology substitutes for some 
biological function which has been impaired [1]. The World Health Organisation (WHO) describes an 
ĂƐƐŝƐƚŝǀĞ ĚĞǀŝĐĞ ĂƐ  ‘ĞƋƵŝƉŵĞŶƚ ƚŚĂƚ ĞŶĂďůĞƐ ĂŶ ŝŶĚŝǀŝĚƵĂů ǁŚŽ ƌĞƋƵŝƌĞƐ ĂƐƐŝƐƚĂŶĐĞ ƚŽ ƉĞƌĨŽƌŵ ƚŚĞ
daily activities esƐĞŶƚŝĂůƚŽŵĂŝŶƚĂŝŶŚĞĂůƚŚĂŶĚĂƵƚŽŶŽŵǇ ?ĂŶĚĂƐƐŝƐƚŝǀĞƚĞĐŚŶŽůŽŐǇĂƐ ‘ĂŶƵŵďƌĞůůĂ
term for any device or system that allows individuals to perform tasks they would otherwise be 
ƵŶĂďůĞ ƚŽ ĚŽ ? [2]. The terminologies  ‘ĂƐƐŝƐƚŝǀĞ ƚĞĐŚŶŽůŽŐǇ ? ĂŶĚ  ‘ĂƐƐŝƐƚŝǀĞ ĚĞǀŝĐĞƐ ? ŚĂǀĞ over time 
been driven towards meaning assistance which is more user centred, rather than terminologies with 
a wide definition referring to generic devices such as walking sticks and wheelchairs [3]. More 
recently the WHO have defined the assistive technology as a subset of health technologies which 
enable individuals to improve or maintain healthy, independent, and productive lives in a dignified 
manner whereas without they may become isolated and impoverished. Furthermore assistive 
products should be purposed to compensate for loss of ability and gradual decline in the individual 
over time whilst also reducing the burden on carers, health care providers, and welfare [4].  
 
Potential assistive technology users 
The availability of the United Kingdom (UK) Census data makes it possible for estimates to be based 
on up-to-date demographic figures, which quote the UK population in 2011 as 56,075,912. A survey 
of disability in Great Britain, carried out by the Office of Population Censuses and Surveys (now the 
Office of National Statistics) in 1989, stated that 13.5% of the adult population of the UK had a 
disability of some kind, and that, of these, 69% had a mobility problem, these percentages 
correspond to the absolute figures of 7,570,248 and 5,223,471 respectively. The same source also 
estimated that 7% of disabled adults, and 10% of adults with a mobility problem used a wheelchair, 
and that 10% of those wheelchairs were of the powered type [5].  
The provision of a powered wheelchair (PWC) can have a significant impact on improving mobility, 
independence and quality of life. However not all persons who would benefit from the use of an 
PWC will meet the prescription criteria. For example, cognitive and visual deficit may exclude the 
individual. Additionally, even when prescribed with an EPW its use can be challenging, especially if 
the user does not have the required fine motor control for collision-free navigation within the home. 
Operating a PWC indoors can present the user and their carers with significant challenges. Physical 
and mental disabilities can also make accurate control of the device a major challenge. Collisions 
with objects and people can be highly detrimental to the rehabilitation and confidence of PWC users, 
particularly if the independent use of the PWC is in jeopardy because an unacceptable risk level, 
which varies from prescriber to prescriber, has been reached.  
Additionally, cognitive and physical ability will deteriorate with time for many PWC users. For 
example, users with Multiple Sclerosis or Motor Neurone Disease will have increasing physical 
difficulty in accessing and moving the joystick  (the prime human machine interface) as well as being 
able to drive safely. This means that users with progressive conditions will require periodic 
assessment and adjustment of the PWC configuration in order to maintain independent and safe 
mobility. These adjustments to the control system mean the user often has to wait several weeks for 
appointments with clinicians, therapists, and technicians. The outcome can be that the user loses 
their independent mobility affecting their quality of life and that of their carers, friends and family. 
One solution to this challenge is to develop a PWC control system which can measure the changes in 
user condition. This information can then be used to adapt the PWC control system to more closely 
match the ability of the user. 
State-of-the-art 
Over the past four decades considerable research has been published on the application of mobile 
robotic assistance to improve the quality of life for the disabled user [6]. According to a systematic 
review by Simpson [6], it was observed that little attention had been paid to user input, user 
feedback, and user confidence, with ŶĞŐůŝŐŝďůĞ ĐŽŶƐŝĚĞƌĂƚŝŽŶ ŽĨ ƚŚĞ ƵƐĞƌƐ ? ĂďŝůŝƚŝĞƐ ĂŶĚ Ěesires. In 
order to investigate the importance of understanding those issues, research was carried out by 
Woods and Watson [7]. They suggested that a  ‘social constructionalist ? ĂƉƉƌŽĂĐŚ ŶĞĞĚĞĚ ƚŽ be 
undertaken in order to ƵŶĚĞƌƐƚĂŶĚ ƚŚĞ ƌĞůĂƚŝŽŶƐŚŝƉ ďĞƚǁĞĞŶ ƵƐĞƌƐ ? Ŷeeds and technological 
requirements and how society views the wheelchair and its user. It was important to question the 
assumption that the current social and technological solutions must automatically be the best.  
There was a broad review of intelligent, or smart, and assistive PWC literature undertaken by 
Simpson in 2006 [6] and another similar review by Faria in 2014 [7]. There have been some projects 
which have evolved or continued [8]-[11] and others initiated [12]-[15]; between 2005 and 2013 
over 4,000 papers were published; however no mass produced device has yet reached the end user, 
according to Garcia et al. [16]. They identified three major problems: that most research is 
undertaken in the Lab without involvement of the stakeholders, in particular the users; the lack of 
availability of suitable sensors; and lack of a standardised platform. 
Another significant issue in the development of assistive PWC technology is the absence of any 
standard bench testing procedure so that research groups can compare the performance of their 
developments. In addition, when evaluating the performance of any assistive system it is essential to 
prove that the technological device is fit for purpose and safe [17]. Most research has not fully 
considered these issues [9], [18] and what may be considered by some researchers as appropriate 
may not be ĂĚĚƌĞƐƐŝŶŐƵƐĞƌƐ ?ŶĞĞĚƐ, or worse may be considered dangerous when applied to real-
world applications. Considering the somewhat complex requirements for keeping the individual user 
in overall control of the actions of the robotic PWC system, most research has concentrated on 
addressing specific issues rather than attempting to define the wide-ranging problem and work 
towards a solution which balances the global variables. 
We have worked closely with one of ƚŚĞǁŽƌůĚ ?Ɛmajor suppliers of PWC control systems, Dynamic 
Controls Ltd. The manufacturer informed us that the problem is essentially profit and cost such that 
the larger the market and the simpler the device the lower the cost, in the case of the assistive 
technology powered wheelchair we find ourselves with the exact opposite: complex unique to the 
individual, or bespoke, equipment. Dynamic Controls Ltd states that without external funding they 
would be unable to develop the required technologies; quite simply they would lose money if they 
did attempt to do so. 
The aim of this research 
The road to developing assistive technology, which is fundamentally a user specific adaption of some 
technology, and making it mass producible for a wide range of users is likely to be a very complex 
and costly one. If, the past 40 years, research into producing a smart assistive powered wheelchair 
has still failed to provide anything but the most basic line following navigation assistance [19], then 
the challenge of developing adaptive smart assistive systems will need to be approached very 
differently. Referring back to the  ‘ƐŽĐŝĂůĐŽŶƐƚƌƵĐƚŝŽŶĂůŝƐƚ ? approach we hypothesise that in order to 
develop a technology that can be adapted, adjusted, and applied to a wide array of user needs, 
there needs to be a commonly acceptable (amongst all stakeholders) range of functionality which 
ŵĞĞƚƐƚŚĞĞŶĚƵƐĞƌ ?ƐŶĞĞĚƐĂŶĚǁŝƐŚĞƐĂƐŽƉƚŝŵĂůůǇĂƐƉŽƐƐŝďůĞ per unit cost. 
This research is an attempt to start at the beginning of the development process by trying to 
understand the relationship between stakeholders and their views on the development and use of 
assistive technology. This will identify some of the reasons why the route of developing assistive 
technology and getting it to the end user appears to be so problematic. There is also clearly a need 
to identify a methodology which can be used to develop cost-effective assistive technology. 
Methodology 
Literature is sparse with regard to PWC stakeholder semantics and the variation of difference in 
definition for each of the stakeholder classes. Therefore, in order to understand the interclass 
relationship and to obtain some measure of the range of functionality common to stakeholders we 
devised a simple questionnaire (see appendix A) which we could circulate to relevant stakeholders. 
The questions were based upon significant experience gained by the authors due their extensive 
involvement in two European Union projects developing powered wheelchair assistive technology, 
SYSIASS [20] and COALAS [21]. A follow-on European Union cluster project called EDECT [22]  
involved the organisation of a stakeholder conference and the undertaking of a user clinical 
evaluation of assistive technologies. It was during the stakeholder conference that some of the 
questionnaires were first circulated to collect data in a semi-structured manner, with the 
stakeholders completing the form themselves having had the questions explained. Data was also 
collected from stakeholders at the 2016 Naidex exhibition [23] in Birmingham, UK and at the 2016 
Independent Living Scotland exhibition [24] where again the questions were explained and the 
responses self registered.  
Questionnaire 
The questionnaire was designed with questions worded in such a way as to encourage the 
stakeholder to reflect on their own opinion, rather than any generally accepted view, by specifically 
directing the questions at the reader. This was re-enforced with instructions, written and verbal, on 
how to answer the questions. There were a total of 12 questions with a rating scale of 1-10, where 1 
denotes  “no, less, or not much ? and where 10 rates as  “yes, greatly, very much, or lots ?. There was 
an additional section for responders to add their personal comments, Table 1.  
Table1. Stakeholder questionnaire comments 
Stakeholder Comment 
User tŝƚŚŝŶƚŚĞE,^ƚŚĞƌĞŝƐĂ ‘ƉĞƌĐĞƉƚŝŽŶ ?ƚŚĂƚǇŽƵĐĂŶďĞĂǁŚĞĞůĐŚĂŝƌƵƐĞƌKZŚĂǀĞ
ƐĞǀĞƌĞŵĞĚŝĐĂůĐŽŶĚŝƚŝŽŶƐ ? ? ? 
User The academic world is FAR [advanced], but we also have to involve the suppliers, 
government etc. 
User There are lots of external factors when using a powered chair that I think are hard to 
measure. 
Policymaker Measuring the quality of life and placing a value on it is vital to make the case for 
public sector spend and take-up. 
Clinician There sometimes needs to be a compromise regarding what the user 
wants/preferences and what is actually most suitable assistive technology [for them]. 
Clinician Unfortunately statutory NHS standard services are risk led as opposed to service 
ĚĞůŝǀĞƌǇĐŽŵŵŽŶƐĞŶƐĞĂƉƉƌŽĂĐŚĞƐ ?ƚŚĞǇĨŽĐƵƐŽŶŽŶĞƐŝǌĞĨŝƚƐĂůů ? ? ? ? 
Clinician KĐĐƵƉĂƚŝŽŶƚŚĞƌĂƉŝƐƚƐĂŶĚ ?ĐůŝŶŝĐĂů ?ƉƌŽĨĞƐƐŝŽŶĂůƐĚŽŶ ?ƚŚĂǀĞĞŶŽƵŐŚŝŶĨůƵĞŶĐĞŽǀĞƌ
ĨŝŶĂŶĐĞƐĂŶĚƐǇƐƚĞŵƐ ?ƚŚĞƌĞĨŽƌĞƌĞƐƚƌŝĐƚŝŶŐƚŚĞƐĞƌǀŝĐĞƵƐĞƌ ?ƐĐŚĂŶĐĞƐŽĨƌĞĐĞŝǀŝŶŐĂ
suitaďůĞĐŚĂŝƌ ? ? ? ? ? ? ? ? ? 
Student Technology is often available but not made accessible to users because of financial 
constraints to limit disappoint/frustration [to users]. 
Questionnaires were handed out in person with an explanation of what was required and why the 
information was required to the following groups of stakeholders: 
x Academic; university or hospital teaching/research. 
x Researcher; university or hospital research. 
x Student; university or hospital student on relevant nursing/caring/medical course. 
x User; those using powered wheelchairs and other devices. 
x Prescriber; occupational therapist/other who directly prescribes PWCs/assistive technology. 
x Clinician; hospital medics whose patients use PWCs and other devices. 
x Carer; person who is involved in the daily care of users. 
x Policymaker; someone who has political decision making in hospitals/governing bodies. 
Participants were asked to indicate with which stakeholder group in the assistive technology field 
they were most strongly affiliated. More than a hundred forms were issued and seventy-four 
stakeholders responded. 
ĂƐĞĚƵƉŽŶƚŚĞĂƵƚŚŽƌƐ ?ƉƌĞǀŝŽƵƐĞǆƉĞƌŝĞŶĐĞƐŝƚǁĂƐĚĞĐŝĚĞĚƚŽĂƐŬ12 closed questions to provide a 
quantitative response. These questions were grouped into four blocks such that each block 
concentrated on a particular theme. The first block of three questions was designed to determine 
whether stakeholders understood the role that users play in the development and provision of 
assistive technology. The second block sought to discover if, by changing roles, stakeholders could 
better understand the issues and problems faced by each other, with the aim of developing more 
focused and effective solutions, e.g. designers experiencing what it is to be a user. Question block 
three investigated the stakeholders ? opinions on trust in technology and the dependence people 
have on finding solutions to all problems through technology, and thus whether technology holds 
the sole answer to solving user needs. The final block attempted to identify the stakeholders ? 
opinions on why so little research reaches the end user in marketable products; whether it is simply 
money, effective application, knowledge and understanding of the devices, or all three. The 
questions, together with a description of the reasoning behind them are as follows: 
1. How much should the user be involved in the development of assistive technology? This 
ƋƵĞƐƚŝŽŶǁĂƐĚĞƐŝŐŶĞĚƚŽĚĞƚĞƌŵŝŶĞƚŚĞƐƚĂŬĞŚŽůĚĞƌ ?ƐǀŝĞǁƐŽŶŚŽǁŵƵĐŚƚŚĞƵƐĞƌƐŚŽƵůĚ
be involved in the development of assistive technology. The notion being that too much 
involvement by too many can end up with technoloŐǇ  ‘ĚĞƐŝŐŶĞĚ-by-ĐŽŵŵŝƚƚĞĞ ? ŽǀĞƌ
engineered and overpriced and not fully suitable for any purpose. 
2. How much do you feel that other stakeholders in assistive technology provision understand 
ƚŚĞĞŶĚƵƐĞƌ ?ƐƉŽŝŶƚŽĨǀŝĞǁ ?In this question, we were attempting to ascertain the general 
feeling amongst stakeholders about how they thought their fellow stakeholders really 
ƵŶĚĞƌƐƚŽŽĚƚŚĞƵƐĞƌ ?ƐƉĞƌƐƉĞĐƚŝǀĞƌĂƚŚĞƌƚŚĂŶƚŚĞŝƌŶĞĞĚƐ ? 
3. When issuing, bƵǇŝŶŐ ?ŽƌƉƌĞƐĐƌŝďŝŶŐĂƐƐŝƐƚŝǀĞƚĞĐŚŶŽůŽŐŝĞƐŚŽǁŵƵĐŚĚŽǇŽƵƚŚŝŶŬƚŚĞƵƐĞƌ ?Ɛ
wishes and desires are taken into account in that process? This is an important question 
ǁŚŝĐŚƐĞĞŬƐ ƚŽĚĞƚĞƌŵŝŶĞƚŚĞ ƐƚĂŬĞŚŽůĚĞƌ ?ƐŽƉŝŶŝŽŶŽŶ ƚŚĞĚĞŐƌĞĞŽĨƵƐĞƌ ŝŶǀŽůǀĞŵĞŶƚ ŝŶ
specifying the assistance they would like to receive; this would possibly be in conflict with 
ŽƚŚĞƌƐƚĂŬĞŚŽůĚĞƌ ?ƐŽƉŝŶŝŽŶƐŽŶǁŚĂƚŝƐƐƵŝƚĂďůĞĨŽƌƚŚĞĞŶĚƵƐĞƌ ? 
4. How much do you think Role Reversal Simulation, giving care givers experience of being a 
care receiver, would help them to better understand and empathise with the care receiver? 
The reasoning behind this question was to investigate the attitude of all stakeholders to 
ƉƵƚƚŝŶŐĐĂƌĞŐŝǀĞƌƐŝŶƚŽƚŚĞƵƐĞƌƐ ?ƌŽůĞƐŽƚŚĂƚƚŚĞǇĐŽƵůĚďĞƚƚĞƌƵŶĚĞƌƐƚĂŶĚƚŚĞŶeed for and 
use of assistive technologies, this stems from the frequent discarding of equipment [25] and 
this attempted to discover if some form of role reversal would be acceptable to help with a 
better understanding of the device and its functionality in assisting users to function more 
independently. 
5. If the opportunity for simulation by role reversal was extended to all stakeholders how much 
do you think that this would help them understand and empathise with one another in the 
process of developing and providing assistive technology? Following on from the previous 
question, this one sought to establish whether stakeholders consider that by all stakeholders 
being involved in the development of assistive technologies by partaking in role reversal 
they could better understand the problems and generate better solutions. 
6. ,ŽǁǁŝůůŝŶŐǁŽƵůĚǇŽƵďĞ ƚŽǀŽůƵŶƚĞĞƌ ƚŽƉƵƚǇŽƵƌƐĞůĨ ŝŶ ƚŚĞƵƐĞƌ ?Ɛ ƌŽůĞ ŝĨǁŽƌŬƐŚŽƉƐǁĞƌĞ
available? By this we meant stakeholders being restricted as if disabled and having to use 
the assistive devices to undertake everyday tasks users need to perform; this question was 
designed to validate the previous two questions. 
7. Do you think users feel more or less isolated from society when using assistive technology? 
During our previous research, powered wheelchair users had reported to us that the carer ?s 
visit was often the only contact they had with other people. Therefore, this question sought 
to establish the perception of all stakeholders towards the benefit or hindrance that comes 
with the reliance upon technology. 
8. ŽǇŽƵĨĞĞů ƚŚĂƚ ƚĞĐŚŶŽůŽŐǇĐĂŶƐŽůǀĞĂůů ƚŚĞĚŝƐĂďůĞĚƵƐĞƌ ?ƐƉƌŽďůĞŵƐĂŶĚĞŶĂďůĞƚŚĞŵƚŽ
have a satisfactory quality of life? This question seeks to look at the very optimistic view that 
technology alone can solve end user problems, and specifically asks whether  ‘Ăůů ? problems 
ĐĂŶďĞƐŽůǀĞĚ ?tĞĞǆƉĞĐƚĞĚƚŽƐĞĞĨƌŽŵƚŚĞĂŶƐǁĞƌƐĂŵŽƌĞƉĞƌƐŽŶĂů ‘ŚŽƉĞ ?ĨƌŽŵƚŚĞƵƐĞƌs, 
carers, and other clinical stakeholders and a middle of the road practical reality approach 
from the technology developing stakeholders.  
9. How far advanced do you think academia is with regard to providing solutions to empower 
disabled users to a level desirable by users? Completing block three set of questions we were 
looking to establish how close stakeholders thought advancements in technology were 
towards providing effective assistive technology. The result of this question would indicate 
whether there was any link between the promised technology and available products. 
10. Do you think that cost is the driving force which restrains the development and adoption of 
new assistive technologies? Financial constraints are often the root cause for the failure of 
technologies to be brought to market. However, in the case of the powered wheelchair, 
having reviewed the literature, the problems seem to be far more complex than are readily 
ĂƉƉĂƌĞŶƚ ?dŚŝƐƋƵĞƐƚŝŽŶŚŽƉĞƐƚŽĐůĂƌŝĨǇƐƚĂŬĞŚŽůĚĞƌƐ ?ŽƉŝŶŝŽŶƐŽŶƚŚĞŝƐƐƵĞŽĨǁŚĞƚŚĞƌĐŽƐƚ
is an issue, the wording being carefully chosen to imply the cost of the end product rather 
than front end costs such as research. 
11. How important is the need to measure the improvements in the quality of life assistive 
technology provides? Previous projects we had undertaken had uncovered a major issue 
with regard to providing users with suitable technology. This was user empowerment; to use 
technology to improve their lives rather than burden them or to make them feel negative 
about their lack of ability. Therefore, this question will establish just how important 
stakeholders thought the measurement of improving quality of life was with when 
developing assistive technology which would then be more likely to reach the end-user. 
12. Should training and coaching for all stakeholders be an important part of the technology 
development and usage cycle? It was expected this question would be very highly rated, 
particularly after encountering this issue in previous projects. It had been reported that 
technology was often left unused because of the lack of understanding of the user/care in 
how to operate the equipment, and the absence of technical support. 
The final section of the questionnaire provided a comment box to gather open opinions where 
strongly held views might be expressed that would add qualitative semantic context to the 
quantitative responses. 
Ethical approval 
This research was subject to ƚŚĞ hŶŝǀĞƌƐŝƚǇ ŽĨ <ĞŶƚ ?Ɛ standard ethical review process for projects 
involving human participation, and met all of its requirements. 
Data analysis 
Due to the consideration that the data is nonparametric in behaviour, WĞĂƌƐŽŶ ?ƐŽƌƌĞůĂƚŝŽŶ which 
measures the linear correlation between two variables [26], and ^ƉĞĂƌŵĂŶ ?ƐZŚŽ gives a measure of 
nonparametric rank correlation [27], and Wilcoxon Signed-Rank Test [28] employed for analysing 
matched-pair data based upon difference; were used to test for consistent differences/similarities in 
agreement between stakeholder groups, whilst we utilised &ůĞŝƐƐ ?Ɛ ŬĂƉƉĂ [29] to determine the 
overall rater reliability within each of the stakeholder groups. 
Median, range, mean and standard deviations for each stakeholder group for each question block 
were compared for data evaluation then presented raw as box plots with the outliers marked as a 
stand-alone red asterisk, the upper and lower (If data falls outside the central rectangular box) 
ĚŽƚƚĞĚůŝŶĞĞŶĚŝŶŐǁŝƚŚĂ ‘d ?ƌĞƉƌĞƐĞŶƚƐƚŚĞ range of data not considered outliers to a maximum of 
3/2 times the height of the central rectangular box. The central box contains data within the range of 
the 25% and 75% quartiles and the mean of the data range is represented by the solid thick red 
horizontal line within the central box. 
Results 
&ůĞŝƐƐ ?Ɛ<ĂƉƉĂ P 
Despite some groups of stakeholders having a relatively low number of participants the result of the 
&ůĞŝƐƐ ?Ɛ<ĂƉƉĂtest, given in Table 2, indicates that there is a reasonable agreement within each of 
the groups for all questions, where zero is no agreement and one is complete agreement. The 
strongest intra-group correlation was the researchers at 0.36, followed by users then policymakers, 
with clinicians having the least intra-group correlation tending towards zero.  
dĂďůĞ ? ?&ůĞŝƐƐ ?Ɛ<ĂƉƉĂƌĞůŝĂďŝůŝƚǇŽĨĂŐƌĞĞŵĞŶƚ 
Group label Fleiss Kappa Number of raters 
Academic   0.073     11 
Researcher   0.355     5 
Student   0.088     10 
User   0.149      9 
Prescriber   0.2      5 
Clinician   0.014     15 
Carer   0.099     11 




It may be inferred from the mean value of responses in Figure 1 that the responders/raters wrongly 
took the question to mean the value of the contribution the user can make towards developing 
assistive technology ƌĂƚŚĞƌƚŚĂŶ ‘ƐŚŽƵůĚ ?ƚŚĞƉƌŽĚƵĐƚĚĞǀĞůŽƉŵĞŶƚďĞƐŽůĞůǇĐŽŶĐĞŶƚƌĂƚĞĚŽŶďĞŝŶŐ
steered by the end user. Although one user, one researcher, and one carer clearly understood the 
question and gave a middle rating indicating that they thought that the development was a process 
for the involvement of other stakeholders. Therefore the ratings were very densely centred on the 
maximum value with one clinician declining to answer this question. 
 
Figure 1. Box plot of ratings for all stakeholders  
Question 2: 
This question had a very wide range of ratings, the median overall ratings for all groups appears to 
straddle the middle rating (Figure 2), although the academics (Figure 3), researchers (Figure 4), 
students (Figure 5), users (Figure 6), and policymakers (Figure 7) were slightly more positive in 
general than the median for all groups. All stakeholders responded by rating the question. 
 Figure 2 ?ŽǆƉůŽƚŽĨŵĞĂŶŵĞĚŝĂŶƌĂƚĞƌ ?ƐƌĂƚŝŶŐǀĂůƵĞs for all groups 
Question 3: 
The prescribers (Figure 8) had a high rating with a low range; the only other stakeholders with 
similar ratings were the clinical students (Figure 5). All other stakeholders had a very wide range of 
ratings although generally more positive than question 2, with the all group mean of the medians 
ƌĂƚŝŶŐŽĨĞŝŐŚƚĐŽŵƉĂƌĞĚƚŽƋƵĞƐƚŝŽŶ ? ?ƐƌĂƚŝŶŐŽĨƐŝǆ ? One prescriber failed to rate this question. 
Question 4: 
The response to this question was for all stakeholders to rate this highly with the mean median 
rating (Figure 2) just under nine. 
 
Question 5: 
The ratings showed that the clinicians, prescribers, and policymakers were rating this question more 
positively than the remaining stakeholders, particularly users (Figure 6) and carers (Figure 9); this 
question rated an average median over eight and was closely grouped around that value. 
Question 6: 
The ratings were a little less compact in the responses to this question but still almost the same 
overall average median of all groups as were the previous two questions (4 and 5), see Figure 2, 
making the block of three questions (4-6) results appear correlated. The only question out of the 
block of three (4-6) which stakeholders failed to answer was this question which was left blank by 
three users. From one ƵƐĞƌ ?Ɛcomment section it was clear that they not think the question applied 
to them, although users had been told to simply replace the word user with other stakeholder such 
as a carer if they were physically able to partake, three users rated the question with a score of ten. 
The response to this question indicates that the concept of role-reversal to better understand the 
problems seems to appeal to all stakeholders, however; the meaning/use may need clarification. 
Question 7: 
The ratings were very wide spread, being based upon stakeholders own experiences. The user group 
had the widest spread of responses with the clinicians (Figure 10), students, and policymakers 
having the narrowest. The researchers, users, carers, and students general opinion was that the 
technology would make users feel less isolated; however the policymakers, followed by the clinicians 
and then the academics were more sceptical. This was the most unanswered question, two 
policymakers, one clinician, one user, one student, and four academics left the answer blank. 
Question 8: 
It was clear from the responses that all of the stakeholders took the question seriously, except one 
academic and one policymaker who failed to rate. The academics having the most positive rating 
followed by the younger students, the clinicians, prescribers, and the policymakers were similarly 
grouped although being generally negative (Figure 7). The answer to this question clearly straddled 
the midway point with a clear divide between the innovators of new technology and those who 
need to apply and prescribe the technology to the end user. The question may also need rephrasing. 
Question 9: 
The students recorded a wholly positive rating in their agreement with the question, followed by the 
prescribers; in contrast the researchers were wholly negative with their rating of the question. All 
other stakeholders were scoring around the centre of the range of rating values. One user and one 
carer chose not to record their answer to the question.  
Question 10: 
This question seeks to clarify ƐƚĂŬĞŚŽůĚĞƌƐ ? opinions on the issue of whether cost is an issue, the 
wording being carefully chosen to imply the cost of the end product rather than front end costs such 
as research. The very high median value of nine for all stakĞŚŽůĚĞƌƐ ? ƌĞƐƉŽŶƐĞƐ ŐŝǀĞŶ ŝŶFigure 1 
indicates a general consensus that end cost is a major issue, although some stakeholders notably the 
researchers thought otherwise, they were very much spread around the middle of the ratings with 
their mean at five being slightly negative. The prescribers were the next group to be less sure that 
cost was the issue having a mean at between seven and eight followed by the user mean at eight. 
These groups (researchers, users, prescribers) also had a very large spread of ratings compared to all 
the other groups who were much tightly bound to the upper end of the scale. Only one prescriber 
failed to respond to this question. 
 
Question 11: 
Policymakers and prescribers were closely bound to the upper ratings between eight and ten with a 
median over nine for both groups. These two were followed very closely by the researchers with a 
mean of nine and a range of seven to ten. The user group had a mean close to ten with a tight 
central range between the upper and lower quartiles around the median, although one user rated 
this category at three, which may indicate that they misunderstood the question or had some other 
personal reason. The remaining stakeholders all had a much wider spread of ratings although their 




The results showed the overall stakeholder median rating was the third highest for all questions, and 
the mean rating for all stakeholders was nine. The academics, researchers, and students had a wider 
range of ratings with a median generally slightly lower than the other stakeholders. The clinicians, 
users, and prescribers had high median ratings and were very closely grouped at the more positive 
end; the ƉŽůŝĐǇŵĂŬĞƌƐ ?ƌĂƚŝŶŐƐĂƌĞĐůŽƐĞƌƚŽƚŚĞĂĐĂĚĞŵŝĐƌĂƚŝŶŐƐ ?ĂůƚŚŽƵŐŚƚǁŽ policymakers did not 
answer the question. 
 
Figure 3. Box plot of academic ratings 
 Figure 4. Box plot of researcher ratings 
 
Figure 5. Box plot of clinical student ratings 
 Figure 6. Box plot of user ratings 
 
Figure 7 Box plot of policymaker ratings 
 Figure 8. Box plot of prescriber ratings 
 
Figure 7. Box plot of carer ratings 
 Figure10. Box plot of clinician ratings 
 
WĞĂƌƐŽŶ ?ƐŽƌƌĞůĂƚŝŽŶ P 
Academics have better than a 0.81 (Table 3) correlation with users, prescribers, and carers, which 
demonstrates the general good understanding academics have of the problems faced by the users. 
The researchers have the closest correlation with the user group at 0.95 followed by clinicians at 0.9, 
the prescribers 0.89, then the carers 0.88, with the remaining stakeholders all better than a 0.75 
correlation. The policymakers clearly have a poor correlation with students at 0.57 and prescribers 
second worse at 0.7 with a much better correlation between users 0.84, clinicians 0.85, and carers at 
0.84. This may however be more of a reflection of the likelihood of the different stakeholder groups 
meeting each other and interacting. 
dĂďůĞ ? ?WĞĂƌƐŽŶ ?ƐŽƌƌĞůĂƚŝŽŶ 
 Academic Researcher Student User Prescriber Clinician Carer Policymaker 
Academic 1.000 0.782 0.719 0.806 0.808 0.739 0.866 0.761 
Researcher 0.782 1.000 0.746 0.946 0.890 0.901 0.882 0.785 
Student 0.719 0.746 1.000 0.804 0.705 0.718 0.815 0.573 
User 0.806 0.946 0.804 1.000 0.851 0.924 0.940 0.836 
Prescriber 0.808 0.890 0.705 0.851 1.000 0.850 0.865 0.699 
Clinician 0.739 0.901 0.718 0.924 0.850 1.000 0.842 0.849 
Carer 0.866 0.882 0.815 0.940 0.865 0.842 1.000 0.838 
Policymaker 0.761 0.785 0.573 0.836 0.699 0.849 0.838 1.000 
 
^ƉĞĂƌŵĂŶ ?ƐZŚŽ: 
According to the results given in Table 4, the group of academics have an agreement correlation 
rank of ш ? ? ? ?ǁŝƚŚƵƐĞƌƐ ?ƌĞƐĞĂƌĐŚĞƌƐ ?ƉƌĞƐĐƌŝďĞƌƐ ?ĐĂƌĞƌƐ ?ĂŶĚƉŽůŝĐǇŵĂŬĞƌƐ ?ZĞƐĞĂƌĐŚĞƌƐŚĂǀĞƚŚĞ
highest correlation of agreement with users at 0.94, clinicians 0.91, and prescribers 0.9 and all 
others greater than 0.79 making them the group with the best statistical fit to all the other groups. 
The agreement between students and policymakers, and also with prescribers, showed a poor 
correlation at 0.64 and 0.65 respectively. 
 
 
dĂďůĞ ? ?^ƉĞĂƌŵĂŶ ?ƐZŚŽ 
 Academic Researcher Student User Prescriber Clinician Carer Policymaker 
Academic 1.000 0.798 0.706 0.792 0.805 0.718 0.827 0.829 
Researcher 0.798 1.000 0.813 0.943 0.899 0.911 0.870 0.838 
Student 0.706 0.813 1.000 0.778 0.650 0.763 0.824 0.643 
User 0.792 0.943 0.778 1.000 0.850 0.903 0.909 0.850 
Prescriber 0.805 0.899 0.650 0.850 1.000 0.851 0.835 0.753 
Clinician 0.718 0.911 0.763 0.903 0.851 1.000 0.779 0.841 
Carer 0.827 0.870 0.824 0.909 0.835 0.779 1.000 0.814 
Policymaker 0.829 0.838 0.643 0.850 0.753 0.841 0.814 1.000 
 
Wilcoxon Signed-Rank Test: 
ResearĐŚĞƌƐŚĂǀĞĂǌĞƌŽǀĂůƵĞŽĨ ‘d ?ĨŽƌĂůůƐƚĂŬĞŚŽůĚĞƌƐĞǆĐĞƉƚƐƚƵĚĞŶƚƐǁŚĞƌĞƚŚĞǀĂůƵĞŝƐ ? ? ? ?ĂŶĚ
academics 2 (Table 5). The lower the number in this test, the stronger the correlation between two 
sets of data; this means that the researchers have a very close statistically significant opinion with all 
stakeholders except students and academics. The clinicians, clinical students, and carers, seem 
ƌĞĂƐŽŶĂďůǇ ĐŽƌƌĞůĂƚĞĚ ǁŝƚŚ ĞĂĐŚ ŽƚŚĞƌ ŚĂǀŝŶŐ Ă  ‘d ? ǀĂůƵĞ ŽĨ  ? ? Žƌ  ? ? ďĞƚǁĞĞŶ ĞĂĐŚ ƉĂŝƌŝŶŐ ? ƚŚĞ
policymakers have a good pairing with clinicians and an even better pairing with academics but a 
poorer paring with prescribers and users. Academics have their best pairing with researchers, 
followed by the clinicians at 7.5, but a worse pairing with the user and prescriber groups. Users have 
their best pairing with researchers and second best with carers at 5.4 then prescribers.  
Table 5. Wilcoxon Signed-Rank Test 
 Academic Researcher Student User Prescriber Clinician Carer Policymaker 
Academic  2 14.5 19.5 24 7.5 10.5 10.5 
Researcher 2  10.5 0 0 0 0 0 
Student 14.5 10.5  18.5 22.5 13 13 21 
User 19.5 0 18.5  12 17.5 5.5 31.5 
Prescriber 24 0 22.5 12  23 13.5 31.5 
Clinician 7.5 0 13 17.5 23  18 12 
Carer 10.5 0 13 5.5 13.5 18  23 
Policymaker 10.5 0 21 31.5 31.5 12 23  
 
Discussion 
When each group of sƚĂŬĞŚŽůĚĞƌƐ ? responses were averaged the range of all the groups when 
combined had a significant clustering, as shown in Figure 2, despite the wide range of individual 
ratings within each group shown in Figure 1. This indicates that there is a general trend with the 
responses to the questions which means we have identified some common ground amongst the 
stakeholders. Not answering a question could have been ĚƵĞƚŽĂƌĞƐƉŽŶĚĞŶƚ ?Ɛ lack of experience in 
a certain area making them feel unable to give an opinion, lack of understanding of the question or 
did not feel the question applied to them and so left the question blank. 
The response to question one clearly places the concept of user involvement in the process of 
assistive technology development as being of paramount importance. However from the wide range 
of ratings to question two, and particularly the common mean trend rating of six (Figure 2), we can 
deduce that although individuals may have differing personal experiences that there is a clear lack 
ƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨƚŚĞƵƐĞƌ ?ƐƉŽŝŶƚŽĨǀŝĞǁ ?ĂŶĚŝĨǁĞƚĂŬĞĂƐŝŵŝůĂƌǀŝĞǁŽŶƚŚĞƌĞƐƉŽŶƐĞƐƚŽƋƵĞstion 
three then we can say that the user is not as involved in the entire assistive technology process as 
much as stakeholders think they should be. 
The second block of questions had a distinct objective to determine stakeholder views on the 
method of role reversal simulation to help them better understand the problems, and whether the 
concept would be taken up by stakeholders as a methodology. The responses from all raters suggest 
that the concept is one which would be acceptable, although due to the slightly less enthusiastic 
response to question six possibly not compulsory. 
The responses to the third block of questions (7-9) were wide ranging and the common trend was 
centred close to the middle rating. Whilst it would be easy to assume that raters misunderstood 
these questions, or that there was a general middle-of-the-road response, when we examine the 
inter-group rating ranges there are distinct differences. Question seven asked whether technology 
would make users feel more or less isolated from society, the responses from the user group closely 
matched the median range of all the stakeholder groups combined. However there was a distinct 
split between clinicians and policymakers who thought users would become more isolated and 
researchers and students who thought that technology would make users less isolated. We surmise 
that this may be due to age and the younger stakeholders being more comfortable with social media 
and the wider opportunities for socialising that this brings; conversely older and severely disabled 
users may not understand or be comfortable using such technology, the professionals being aware 
of this problem.  
Question eight was aimed at determining the simplistic view of whether stakeholders believed 
ƚĞĐŚŶŽůŽŐǇŚĂĚĂůůƚŚĞĂŶƐǁĞƌƐƚŽƵƐĞƌ ?ƐƉƌŽďůĞŵƐ ?The assumption was that the technologists would 
have a neutral view around the rating of five to six and for the users, carers and medical 
ƉƌŽĨĞƐƐŝŽŶĂůƐƚŽŚĂǀĞĂŚŝŐŚĞƌƌĂƚŝŶŐŽƉŝŶĞĚƚŚĂƚƚĞĐŚŶŽůŽŐǇĐĂŶƐŽůǀĞ ‘Ăůů ?ƚŚĞƉƌŽďůĞŵƐ ?Although 
the technologists were tightly clustered close to centre point as expected, the response from the 
researcher group was wholly on the negative side of the centre point whereas the academics were 
wholly on the higher positive side. Most of the other stakeholder groups each had a wide range of 
ratings, some spanning the whole spectrum of ratings, with their median response at the mid-point. 
The policymaker median was slightly more positive and the user group median more negative. The 
responses appear to support our hypothesis suggesting that the problems and solutions might be 
divided between social and technological and therefore assistive technology development should 
consider the social impact. 
The next question and the last in this third group of questions sought to establish how far advanced 
different stakeholders thought academia was with progress towards providing solutions to empower 
users to a level they would desire. The researchers were wholly negative and the students wholly 
positive with the academics nearly all on the positive side of the centre point. The prescribers were 
also mainly positive with their median rating of six. All of the other stakeholders were widely ranged 
but with their medians centred towards the mid-point. The implication here is that academics, 
prescribers, and the clinical students have a belief that academia is reasonably advanced with regard 
to providing solutions where in reality, as stated previously, little has been brought to market 
because of the complex problems which need to be overcome, as the researchers low ratings imply.  
Stakeholders mostly rated question 10 ? does cost restrain the development and adoption of new 
technology ? towards the maximum rating which makes this the second highest rated question after 
number one. The academics, carers, and policymakers all had a median rating of nine firmly holding 
the opinion that cost was the driving force. Most other groups had their median rating at either 
seven or eight with the exception of the researchers who had their median slightly negative at five 
and their quartile range between three and eight making this group appear to imply that cost was 
only one factor rather than the driving force, some users, clinicians, prescribers, and policymakers 
widened their respective group spread of ratings towards the centre point supporting this notion. 
The importance of assistive technology improving the quality of life was the basis for question 11 
with the users rating median of 10 and the quartile range nine to ten, the ƌĞƐĞĂƌĐŚĞƌ ?Ɛ median rating 
of nine and quartile range eight to nine. Most other stakeholders considered this very important 
with the quartile upper to lower range for all raters between eight and 10. Therefore all stakeholders 
accept that quality of life improvement should be a major requirement when developing new 
technology; however the literature appears to lack this consideration.  
Finally question 12 asks whether training and coaching for all stakeholders should be part of the 
assistive technology development cycle. The responses from all stakeholders was to rate this 
question towards the maximum value, although not quite as highly as question 11. We postulate 
that this response is because stakeholder opinions would be based upon their experience of many 
technological devices failing to function satisfactorily, too complicated to understand, or not suitable 
for the application and the idea of having all stakeholders involved in the development with the 
technology explained to them as it progresses whilst also providing ongoing support for them during 
the usage cycle is thus appealing. Solving the problems posed in this last group of three questions 
we believe would improve the very negative responses to the third group of questions particularly 
number eight.  
When we analyse the inter-group correlations we might expect that academics would have a close 
pairing with their researchers and also a good pairing with clinicians, particularly as medical research 
projects involve collaboration between academics and clinicians. We would also expect academics 
not to frequently meet users as their researchers would be an intermediary; furthermore they would 
very infrequently meet prescribers and therefore share even less in common with this group. 
Researchers have the closest pairing to all groups, which we would expect to be the case, as they are 
working and communicating with all stakeholders and knowledgeable within the art in a specialised 
way. Policymakers, academics, clinicians, and researchers are also likely to meet and discuss 
research projects, particularly in light of funding applications; therefore the pairings shown in this 
test are closer between these groups. The policymakers probably have little chance to meet users, 
carers, and students hence the worse pairings are with these groups. Despite small differences, in 
general this test has also confirmed that all stakeholders appear to have a reasonably good common 
understanding of the challenges underlying the questions in the questionnaire. 
Conclusions 
From this research it is clear that for assistive technologies to be effectively deployed they must, in 
ĂĚĚŝƚŝŽŶƚŽďĞŝŶŐƐƵŝƚĂďůĞĨŽƌƚŚĞĞŶĚƵƐĞƌ ?ƐŶĞĞĚs, be supported by providing: 
x Specific role reversal or immersion into other stakeholder environments during training to 
use the technology for prescribers and carers, and in general for all stakeholders when the 
technology is first being developed in order to better understand the problems. 
x Feedback from the user about, and ongoing monitoring of, their quality of life when using 
the technology, to all other stakeholders, and in particular technicians and clinicians. 
x Ongoing training (re-training) and technical support should be readily available to users and 
other stakeholders to ensure the devices do not become discarded or damaged and remain 
fit for the purpose they were designed. 
x Better social and professional interaction should take place between stakeholders to share 
knowledge and exchange experiences rather than remain isolated in their respective groups. 
x A consideration for funders must be the need for the involvement of all the stakeholders in 
assistive technology research together with a strong industrial partnership if these devices 
are to reach the end user. 
Furthermore, we conclude that any methodology for improving the uptake of technology into the 
market place and onto the end user should involve the following: 
x engaging assistive technology users, and all other stakeholders, in regular discussion to 
determine the problems that require solutions, and also iteratively evaluate these solutions 
during development phases of the equipment; 
x establish if there is a grouping of many user problems which can be solved by one type of 
adaptable and adjustable device; 
x determine the number of users and undertake a typical marketable device cost-benefit 
analysis with involvement of the manufacturer; 
x obtain public funding with a manufacturer in partnership to undertake the research; 
x involve all stakeholders in the development and evaluation of the device. 
Finally, we concluded that the device should: 
x decrease user isolation; 
x be capable of being monitored for determination of the improvement in the quality of life; 
x have ample technical support and training; 
x be cost effective; 
x be adjustable and adaptable to a wide range of users; 
x be easily operated by anyone; 
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